l-carnitine in liver promotes regeneration after hepatectomy by enhancing lipid metabolism | Journal of Translational Medicine Representative photomicrographs of liver sections
Description
It is advisable for those with kidney disease to avoid taking high doses of L-carnitine without medical supervision
Are cytoskeletal components involved in the control of hepatic carnitine palmitoytransferase I activity
Chronic high-dose use may not be wise for someone with cardiovascular disease risk, high LDL cholesterol, kidney disease, or a medical history that already warrants monitoring
Perfect for those who prefer a versatile alternative to capsules or powders
Supplemental Fig
The cause of death was neonatal CPT II deficiency
